Corticosteroid Therapy Guideline

Introduction to Corticosteroid Therapy

• The British Association of Dermatologists suggests that equivalent doses should be maintained when switching between corticosteroids for inflammatory conditions, to ensure appropriate conversion and minimize potential side effects 1

Indications for Corticosteroid Therapy

• Methylprednisolone is indicated for patients with symptoms suggesting asthma or asthma variants, including chest congestion with wheezing, persistent cough unresponsive to bronchodilators, associated rash suggesting an allergic component, and cough variant asthma with normal spirometry but airway hyperresponsiveness, as recommended by the American College of Chest Physicians 2
• The American College of Chest Physicians recommends against systemic corticosteroids for routine treatment of acute bronchitis, but methylprednisolone may be useful in cases of severe asthma exacerbations or suspected allergic reactions 2
• Cough variant asthma is characterized by eosinophilic airway inflammation without airway hyperresponsiveness and responds well to corticosteroid therapy, with a strength of evidence supported by 3
• The American Academy of Allergy, Asthma, and Immunology suggests IV methylprednisolone for severe asthma exacerbations unresponsive to initial treatments 4
• The British Association of Dermatologists recommends IV methylprednisolone for severe pemphigus vulgaris and bullous pemphigoid 1, 5
• The American Society of Clinical Oncology recommends prednisone 1 mg/kg/day (or equivalent dose of methylprednisolone) for grade 2 immune-mediated colitis, and intravenous methylprednisolone 1-2 mg/kg/day for grade 3-4 immune-mediated colitis 6
• The National Comprehensive Cancer Network suggests methylprednisolone 1000 mg/day IV for 3 days, followed by a rapid taper, for grade 4 CRS refractory to dexamethasone 7

Corticosteroid Conversion and Dosing

• The following corticosteroid equivalent doses and relative potencies are recommended:

• The conversion ratio addresses dose equivalence but not duration of effect, and dosing frequency should be adjusted based on the half-life of the specific steroid, according to the American Society of Health-System Pharmacists 8
• For asthmatic cough refractory to inhaled corticosteroids, a short course (1-2 weeks) of systemic corticosteroids is recommended, with a strength of evidence supported by the American College of Chest Physicians 2

Monitoring and Adverse Effects

• Hyperglycemia is a potential adverse effect of methylprednisolone, especially following initial bolus, and monitoring is recommended, especially in diabetic patients, as stated by the American Diabetes Association 9, 10
• Surveillance for infections is recommended as corticosteroids may blunt fever response, with a strength of evidence supported by 10
• Patients should be monitored for adverse effects, such as hypertension and electrolyte disturbances, as recommended by the American Diabetes Association 9
• High-risk patients should consider prophylaxis for Pneumocystis pneumonia, gastric protection, and osteoporosis prevention for prolonged courses, as advised by relevant medical societies 9, 8

Administration and Withdrawal

• High-dose therapy should be administered over at least 30 minutes to reduce the risk of cardiac arrhythmias, as recommended by the American College of Cardiology 11
• The medication should be withdrawn gradually rather than abruptly after long-term therapy, to minimize the risk of adverse effects, as suggested by the Endocrine Society 12
• IV methylprednisolone should be used judiciously, with careful consideration of both benefits and risks, and dosage requirements must be individualized based on the disease being treated and patient response, as recommended by the European League Against Rheumatism 13